What separates a proper cell facility from an ordinary lab
Quick answer
Cells used for kidney treatment must be produced in a GMP facility with environmental control and per-batch testing for bacteria, fungi, mycoplasma and endotoxin, plus viability, purity and karyotype stability checks before release. Always ask to see the batch certificate of analysis.
GMP is not just a clean room; it is documentation and traceability from the incoming sample to the bag delivered to the patient. Every step records who did what, when, with which material lot — that is what makes problems traceable.
EHL Bio states that it operates a GMP cell manufacturing centre for its own therapies, including the renal-focused KDSTEM inj. Whatever programme you consider, ask plainly where the cells are made and who is accountable for quality.
Red flags: refusing to share documentation, claiming everything is a trade secret, or infusing outside a licensed medical facility. Kidney patients carry above-average infection risk and should accept no shortcuts.
Compliant providers can usually supply or at least show it; a blanket refusal is a warning sign.
Not necessarily, provided freezing and thawing are validated; what matters is viability at the time of infusion.
ISO is general quality management; GMP is specific to manufacturing medicines and biologics that enter the body.
The batch is discarded and the process restarts, which can delay treatment — ask how costs are handled in that case.
Some Thai facilities operate under national oversight; verify licences case by case.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr/rd/institute/
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories